As per the report of Market Data Forecast, the size of the Global Superdisintegrants Market is projected to reach USD 332.47 Million in 2019 and estimated to be growing at a CAGR of 7.8%, to reach USD 484 Million by 2024.
Increasing healthcare expenditure and healthcare awareness among individuals has accounted for the growth of this market. Superdisintegrants are one of the many kinds of excipients utilized in the pharmaceutical industry for tablet-based drug administration. Disintegrants are substances that expand and dissolve when wet causing the tablet to break apart in the digestive tract, releasing active ingredients for absorption. They make sure that when the tablet is in contact with water, it breaks down rapidly into smaller fragments making way for dissolution, thus reducing the time required for the drug release.
The growth of the Superdisintegrants market is attributed to factors like the growing population of geriatric and pediatric patients, growing generic drugs market, and the development of new Superdisintegrants in the pharmaceutical industry. However, the growth of the market is hindered by the declining financial support for R&D fields. Although synthetic Superdisintegrants have been the standard for many decades now, greater research into natural Superdisintegrants will provide a motivation for the future growth of the market.
Increasing demand to manufacture highly accurate and effective drugs with appropriate dosage levels of various excipients and active ingredients is elevating the demand of the market. A rise in the expenditure on healthcare along with growing disposable income in urban areas is straightly lavishing the growth of the market.
The main goal of the drug manufacturers is to reduce the dissolving time of a tablet in the digestive part and release active ingredients which is solely to set up growth opportunities for the market. Growing prevalence for producing generic drugs is also fueling the growth of the market. Rising incidences of chronic diseases and other health disorders due to changes in lifestyle and food habits are creating chances for the market to grow eventually.
REPORT COVERAGE
|
Report Metric |
Details |
|
Market Size Available |
2018 – 2024 |
|
Base Year |
2018 |
|
Forecast Period |
2019 – 2024 |
|
Segments Analysed |
By Product Type, Application, Therapeutic Area & Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Analysed |
North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
|
Companies Analysed |
Ashland, BASF SE, FMC Corporation, JRS Pharma, DFE Pharma, Roquette, The Dow Chemical Company, Asahi Kasei Corporation, Nippon Soda Co, Huber Corporation |
This research report on Global Superdisintegrants Market has been segmented and sub-segmented into the following categories and calculated market size and forecast to each segment until 2024
Superdisintegrants Market – By Product Type
On the basis of product type, Natural super disintegrants have the highest growth rate from the past decade. Increasing prevalence for the organic raw materials to manufacture various drugs which configure lower side effects is prompting the demand of the market.
Superdisintegrants Market – By Application
On the basis of application, the Capsules category is witnessed in holding the highest shares of the market. The increasing production rate of the drugs to meet the requirements from the end-users is escalating the growth of the superdisintegrants market.
Superdisintegrants Market – By Therapeutic Area
On the basis of the therapeutic area, Gastrointestinal diseases area is leading with dominant shares of the market. Growing popularity towards over-the-counter drugs is a common factor for the market to grow extensively. Also, the rise in the support from the private and public organizations through investments mainly to improve the quality of treatment procedures is leveraging the demand of the market.
Regional Analysis:
North America is leading the market while Europe is in second place. Increasing financial support for the development of innovative oral dosage forms and constant effort devoted towards providing superior quality and compliant products in the market are the primary factors responsible for the dominance of North America and Europe in the market.
The Asia Pacific is expected to grow the fastest due to increasing healthcare spending, rising healthcare infrastructure and awareness and increasing outsourcing of excipient manufacturing to Asian countries like India and China. The synthetic superdisintegrants market segment held the largest share of the global superdisintegrants market.
This is mainly accounted for the prevalent use of excipients such as sodium starch glycolate, and crospovidone in orally and fast disintegrating tablets. Rising incidences of cardiovascular diseases, neurological diseases, and other related diseases are further expected to drive the demand of fast disintegrating tablets, in-turn driving the demand of Superdisintegrants during the forecast period.
Some of the noteworthy companies operating in the Global Superdisintegrants Market are:
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product Type
5.1.1 Introduction
5.1.2 Natural Superdisintegrants
5.1.3 Synthetic Superdisintegrants
5.1.3.1 Modified Starch
5.1.3.2 Crospovidone
5.1.3.3 Modified Cellulose
5.1.3.4 Ion Exchange Resins
5.1.3.5 Calcium Silicates
5.1.4 Others
5.1.5 Y-o-Y Growth Analysis, By Product Type
5.1.6 Market Attractiveness Analysis, By Product Type
5.1.7 Market Share Analysis, By Product Type
5.2 Application
5.2.1 Introduction
5.2.2 Capsules
5.2.3 Tablets
5.2.4 Y-o-Y Growth Analysis, By Application
5.2.5 Market Attractiveness Analysis, By Application
5.2.6 Market Share Analysis, By Application
5.3 Therapeutic Area
5.3.1 Introduction
5.3.2 Gastrointestinal diseases
5.3.3 Neurological diseases
5.3.4 Oncology
5.3.5 Infectious Diseases
5.3.6 Cardiovascular Diseases
5.3.7 Haematological diseases
5.3.8 Inflammatory Diseases
5.3.9 Y-o-Y Growth Analysis, By Therapeutic Area
5.3.10 Market Attractiveness Analysis, By Therapeutic Area
5.3.11 Market Share Analysis, By Therapeutic Area
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product Type
6.1.3.3 By Application
6.1.3.4 By Therapeutic Area
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product Type
6.1.4.3 By Application
6.1.4.4 By Therapeutic Area
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product Type
6.1.5.3 By Application
6.1.5.4 By Therapeutic Area
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Ashland
8.1.1 Overview
8.1.2 Product Type Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 BASF SE
8.3 FMC Corporation
8.4 JRS Pharma
8.5 DFE Pharma
8.6 Roquette
8.7 The Dow Chemical Company
8.8 Asahi Kasei Corporation
8.9 Nippon Soda Co.
8.10 Huber Corporation
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
